Sinclair Pharma's new chief executive and two non-executive directors all increased their shareholdings after the specialist pharma company's recent fundraising. Sinclair raised £18.2m - £16m after expenses - at 32p a share to finance the purchase of Flammazine and Flammacerium, which are creams to prevent infections in burns, from Solvay. Sinclair paid €17.5m to Solvay for the two products, which generate annual revenues of more than £9m. Chief executive Chris Spooner has invested nearly £822,000 in the shares at 32p each. He increased his stake from 3.85m shares to 6.42m shares, which gives him 4% of the company. Jean-Charles Tschudin invested £60,799 and chairman Grahame Cook invested £32,000. Cook owns 700,000 shares and Tschudin 632,388 shares. Godalming-based Sinclair is quoted on the Main Market and Euronext Paris. It specialises in dermatology and oral health products. Top Director BuysSinclair Pharma (SPH) Director name: Mr Chris SpoonerAmount purchased: 2,568,140 @ 32.00p Value: £821,805Sinclair Pharma (SPH) Director name: Mr Jean-Charles TschudinAmount purchased: 189,997 @ 32.00p Value: £60,799The Capital Pub Company (CPUB) Director name: Mr Clive WatsonAmount purchased: 50,000 @ 71.00p Value: £35,500Sinclair Pharma (SPH) Director name: Mr Grahame CookAmount purchased: 100,000 @ 32.00p Value: £32,000Game Group (GMG) Director name: Ms Ishbel Jean Stewart MacphersonAmount purchased: 20,000 @ 99.69p Value: £19,938Baillie Gifford Shin Nippon (BGS) Director name: Mr Iain McLarenAmount purchased: 10,000 @ 117.89p Value: £11,789Top Director SellsBlackstar Group (BLCK) Director name: Mr Julian TregerAmount sold: 250,000 @ 52.00p Value: £130,000Dairy Farm International (Singapore) (DFI) Director name: Mr Ronald J FlotoAmount sold: 20,900 @ $6.16 Value: $128,821Topps Tiles (TPT) Director name: Mr Nick D OunsteadAmount sold: 100,000 @ 92.50p Value: £92,500